Publicaciones en colaboración con investigadores/as de Universitat de Barcelona (24)

2024

  1. Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion

    European Journal of Endocrinology, Vol. 190, Núm. 6, pp. 458-466

  2. Glucose metabolism outcomes after pituitary surgery in patients with acromegaly

    Pituitary

2023

  1. Effect of Obesity on Clinical Characteristics of Primary Aldosteronism Patients at Diagnosis and Postsurgical Response

    The Journal of clinical endocrinology and metabolism, Vol. 109, Núm. 1, pp. e379-e388

  2. Executive summary of the SEEN (Sociedad Española de Endocrinología y Nutrición [Spanish Society of Endocrinology and Nutrition])-SEGO (Sociedad Española de Ginecología y Obstetricia [Spanish Society of Gynaecology and Obstetrics]) consensus document on the management of thyroid dysfunction during pregnancy

    Endocrinologia, Diabetes y Nutricion, Vol. 70, pp. 38-50

  3. Executive summary of the SEEN-SEGO consensus document on the management of thyroid dysfunction during pregnancy

    Progresos de Obstetricia y Ginecologia, Vol. 66, Núm. 1, pp. 42-55

2021

  1. Fatty liver index as a predictor for type 2 diabetes in subjects with normoglycemia in a nationwide cohort study

    Scientific Reports, Vol. 11, Núm. 1

  2. Inter-Individual Variability in Insulin Response after Grape Pomace Supplementation in Subjects at High Cardiometabolic Risk: Role of Microbiota and miRNA

    Molecular Nutrition and Food Research, Vol. 65, Núm. 2

2020

  1. Incidence of diabetes mellitus in Spain as results of the nation-wide cohort di@bet.es study

    Scientific Reports, Vol. 10, Núm. 1

2017

  1. Tratamiento con hormona de crecimiento en pequeños para la edad gestacional en España

    Anales de Pediatria, Vol. 86, Núm. 5, pp. 249-254

2016

  1. Prevalencia, diagnóstico, tratamiento y control de la hipertensión arterial en España. Resultados del estudio Di@bet.es

    Revista Espanola de Cardiologia, Vol. 69, Núm. 6, pp. 572-578

2014

  1. Prevalence of plasma lipid abnormalities and its association with glucose metabolism in Spain: The di@bet.es study

    Clinica e Investigacion en Arteriosclerosis, Vol. 26, Núm. 3, pp. 107-114

  2. The efficiency of telemedicine to optimize metabolic control in patients with type 1 diabetes mellitus: Telemed study

    Diabetes Technology and Therapeutics, Vol. 16, Núm. 7, pp. 435-441

  3. Variable patterns of obesity and cardiometabolic phenotypes and their association with lifestyle factors in the Di@bet.es study

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 24, Núm. 9, pp. 947-955

2013

  1. Consumo de fármacos relacionados con el tratamiento de la diabetes mellitus y otros factores de riesgo cardiovascular en la población española. Estudio Di@bet.es

    Revista Espanola de Cardiologia, Vol. 66, Núm. 11, pp. 854-863

  2. Factors affecting levels of urinary albumin excretion in the general population of Spain: The Di@bet.es study

    Clinical Science, Vol. 124, Núm. 4, pp. 269-277

  3. Factors determining high-sensitivity C-reactive protein values in the Spanish population. Di@bet.es study

    European Journal of Clinical Investigation, Vol. 43, Núm. 1, pp. 1-10

  4. Mediterranean diet adherence in individuals with prediabetes and unknown diabetes: The Di@bet.es study

    Annals of Nutrition and Metabolism, Vol. 62, Núm. 4, pp. 339-346

  5. Olive oil has a beneficial effect on impaired glucose regulation and other cardiometabolic risk factors. Di@bet.es study

    European Journal of Clinical Nutrition, Vol. 67, Núm. 9, pp. 911-916

  6. Prevalence of the metabolic syndrome in Spain using regional cutoff points for waist circumference: The di@bet.es study

    Acta Diabetologica, Vol. 50, Núm. 4, pp. 615-623

2012

  1. Evaluation of health-related quality of life according to carbohydrate metabolism status: A Spanish population-based study (Di@bet.es Study)

    International Journal of Endocrinology, Vol. 2012